数字农科院2.0

alpha beta T-cell receptor bias in disease and therapy

文献类型： 外文期刊

作者： Wang, Chun-Yan;Yu, Pei-Fa;He, Xiao-Bing;Fang, Yong-Xiang;Cheng, Wen-Yu;Jing, Zhi-Zhong;Jing, Zhi-Zhong

作者机构：

关键词： T cell receptors;alpha beta TCR;complementary determining region;TCR diversity;TCR bias;immunotherapy

期刊名称： INTERNATIONAL JOURNAL OF ONCOLOGY

ISSN：

年卷期：

页码：

收录情况： SCI

摘要： The diversity and specificity of T cell receptors (TCR), the characteristics of T-cell surface marker, are central to the adaptive immunity. TCR variability is required for successful immunization coverage because this structural foundation is indispensable for the valid identification of short antigen peptides (derived from degraded antigens) that are presented by major histocompatibility molecules on the surfaces of antigen-presenting cells. Despite the vast T-cell repertoire, biased alpha beta TCR has become a common theme in immunology. To date, numerous examples of TCR bias have been observed in various diseases. Immunotherapy strategies that are based on alpha beta T cell responses are also emerged as a prominent component of clinical treatment. In the present review, we briefly summarize the current knowledge regarding basic structural information and the molecular mechanisms underlying TCR diversity. Moreover, we outline the role of TCR repertoire bias in some diseases, and its application for therapeutic interventions, as these play significant roles in disease progression, even with patients with a good prognosis.

分类号： R73

  • 相关文献

[1]Development of a neutralizing mouse-pig chimeric antibody with therapeutic potential against Haemophilus parasuis in Pichia pastoris. Chai, Zheng,Fu, Fang,Jiang, Fucheng,Tian, Huabin,Wang, Zhuo,Zheng, Nan,Zhang, Xueyun,Wang, Xiangling,Li, Xi.

[2]Synergy between Toxoplasma gondii type I Δ GRA17 immunotherapy and PD-L1 checkpoint inhibition triggers the regression of targeted and distal tumors. Yu Chao Zhu,Hany M. Elsheikha,Jian Hua Wang,Shuai Fang,Jun Jun He,Xing Quan Zhu,Jia Chen. 2021

[3]Editorial: Mechanisms of Epigenetics and Genetics in Leukemogenesis. Li Y.,Gao F.,Liu S.. 2022

[4]Senecavirus A as an Oncolytic Virus: Prospects, Challenges and Development Directions. Dankun Luo,Haiwei Wang,Qiang Wang,Wenping Liang,Bo Liu,Dongbo Xue,Yang Yang,Biao Ma. 2022

[5]Palmitoylation landscapes across human cancers reveal a role of palmitoylation in tumorigenesis. Yue Kong,Yugeng Liu,Xianzhe Li,Menglan Rao,Dawei Li,Xiaolan Ruan,Shanglin Li,Zhenyou Jiang,Qiang Zhang. 2023

[6]Allergies to Allergens from Cats and Dogs: A Review and Update on Sources, Pathogenesis, and Strategies. An, Wei,Li, Ting,Tian, Xinya,Fu, Xiaoxin,Li, Chunxiao,Wang, Zhenlong,Wang, Jinquan,Wang, Xiumin. 2024

[7]Boosting chemotherapy of bladder cancer cells by ferroptosis using intelligent magnetic targeting nanoparticles. Cai X.,Ruan L.,Wang D.,Zhang J.,Tang J.,Guo C.,Dou R.,Zhou M.,Hu Y.,Chen J.. 2024

[8]Huqi formula suppresses hepatocellular carcinoma growth by modulating the PI3K/AKT/mTOR pathway and promoting T cell infiltration. Donghao Yin,Xiang Li,Xuemeng Yang,Xiaofei Shang,Zhen Li,Jiahao Geng,Yanyu Xu,Zijing Xu,Zixuan Wang,Zimeng Shang,Zhiyun Yang,Linlan Hu,Quanwei Li,Jiabo Wang,Xinhua Song,Xiuhui Li,Xiaojun Wang. 2025

[9]Intervention in the Crosstalk between the cGAS-STING Pathway and Autophagy Using an Oligonucleotide-Based Bioorthogonal Platform for Amplifying Immunotherapy. Xu, Guoshi,Shu, Yinuo,Jiang, Minhao,Zhang, Yanjie,Zhu, Jiawei,Peng, Yinghua,Pu, Fang,Ren, Jinsong,Qu, Xiaogang. 2025

[10]Metabolic Reprogramming of Adaptive Immunity Induced by Viral Infections. Tong, Guoshuai,Dai, Jingwen,Liu, Qianqian,Gao, Xu,Li, Su,Qiu, Hua-Ji. 2025

作者其他论文 更多>>